Biography
Matthew A. Karlyn has 25 years of experience in working with companies in the healthcare, pharmaceutical, medical device, and technology industries on a wide range of commercial life sciences, licensing, and technology transactions.
Matthew regularly advises pharmaceutical, medical device, and digital health clients on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to the procurement, development, commercialization, and use of regulated life sciences products. He has also worked with a number of clients on corporate transactions including mergers and acquisitions, as well as private equity and venture capital financing.
Matthew has broad experience in intellectual property and technology licenses, collaboration and development transactions, commercialization agreements, and supply and manufacturing transactions.
His clients range from Fortune 100 companies to start-ups, and he regularly advises companies on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to the procurement, development, commercialization, and use of technology and life sciences products. He has also worked with a number of clients on corporate transactions including mergers and acquisitions, as well as private equity and venture capital financing.
Clients rely on Matthew for his breadth of knowledge in licensing, collaboration, and commercialization strategies across a wide range of transactions designed to strengthen operations and maximize value. Matthew’s clients come from sectors across the global economy and include emerging companies, privately held companies, and many of the world’s biggest brands.
Matthew received his B.A. from Union College, J.D. from Temple University, and M.B.A. from the University of Chicago.